You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human Papillomavirus Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Implications of HPV Infection in Male IBD Patients

Not yet recruiting
  • HPV Infection
  • +2 more
  • Anal pap smear and oral swab for cytology and HPV testing
  • Barcelona, Spain
    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sa
Jun 26, 2023

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)

Not yet recruiting
  • HPV Infection
  • Urine Sample Collection
  • +2 more
  • Dhaka, Bangladesh
  • +7 more
Nov 10, 2023

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease Trial in Mexico City (CYD Dengue Vaccine, Human

Completed
Has Results
  • Dengue Fever
  • +2 more
  • CYD Dengue Vaccine
  • Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant
  • Mexico City, Mexico
    (unnamed)
Mar 15, 2022

HPV InfectioN, HPV-Related Carcinoma Trial in China (Recombinant 14-Valent Human Papillomavirus Vaccine(Insect Cell), )

Active, not recruiting
  • HPV InfectioN
  • HPV-Related Carcinoma
  • Recombinant 14-Valent Human Papillomavirus Vaccine（Insect Cell）
  • placebo
  • Nanning, Guangxi, China
  • +4 more
Sep 10, 2023

Human Papillomavirus Infection Trial in Kunming (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Active, not recruiting
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
  • GARDASIL® 9
  • Kunming, Yunnan, China
    Yunnan Center for Disease Prevention and Control
Dec 23, 2022

Papillomavirus Infections Trial in Quzhou, Shaoxing (V503)

Active, not recruiting
  • Papillomavirus Infections
  • V503
  • Quzhou, Zhejiang, China
  • +1 more
Aug 17, 2022

Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Hepatitis E Virus Infection Trial in Hanzhou

Active, not recruiting
  • Human Papilloma Virus Infection Type 16
  • +2 more
  • Cecolin
  • Hecolin
  • Hanzhou, Zhejiang, China
    Zhejiang Provincial Center for Disease Control and Prevention
Jun 8, 2022

Dengue Fever, Dengue Hemorrhagic Fever, Human Papillomavirus Disease Trial in Malaysia (CYD Dengue Vaccine, Human Papillomavirus

Completed
Has Results
  • Dengue Fever
  • +2 more
  • CYD Dengue Vaccine
  • Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant.
  • Klang, Malaysia
  • +4 more
Mar 15, 2022

Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles Trial in Shaoxing, Wuyi

Active, not recruiting
  • Human Papilloma Virus Infection Type 16
  • +4 more
  • HPV+MMR（0d），HPV（6m）
  • +2 more
  • Shaoxing, Zhejiang, China
  • +1 more
Mar 14, 2022

Cervical Intraepithelial Neoplasia, Cervical Cancer, Vaginal Intraepithelial Neoplasia Trial in Dongtai (Recombinant Human

Completed
  • Cervical Intraepithelial Neoplasia
  • +4 more
  • Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin®
  • Dongtai, Jiangsu, China
    Dongtai City Center for Disease Control and Prevention Dongtai,
Jun 22, 2022

HPV Infection, HPV-Related Cervical Carcinoma Trial in Liuzhou (Biological/Vaccine: 11-valent recombinant human papilloma virus

Active, not recruiting
  • HPV Infection
  • HPV-Related Cervical Carcinoma
  • Biological/Vaccine: 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)
  • 9-valent HPV vaccine（Gardasil 9）
  • Liuzhou, Guangxi, China
    Liucheng Center for Disease Control and Prevention
Feb 13, 2022

HPV InfectioN, HPV-Related Carcinoma Trial in China (11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha),

Recruiting
  • HPV InfectioN
  • HPV-Related Carcinoma
  • 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)
  • placebo
  • Hechi, Guangxi, China
  • +7 more
Jun 5, 2022

Cervical Intraepithelial Neoplasia, Cervical Cancer, Condylomata Acuminata Trial in Nanjing, Chengdu (Nonavalent HPV vaccine,

Active, not recruiting
  • Cervical Intraepithelial Neoplasia
  • +2 more
  • Nonavalent HPV vaccine
  • Bivalent HPV vaccine
  • Nanjing, Jiangsu, China
  • +1 more
Feb 10, 2022

Female HPV Vaccination in China

Recruiting
  • Human Papillomavirus Vaccines
  • +4 more
    • Fuzhou, Fujian, China
    • +5 more
    Jul 5, 2023

    Efficacy and Adverse Effects of HPV Vaccination in Chinese Women

    Recruiting
    • Human Papillomavirus Vaccines
    • +4 more
      • Fuzhou, Fujian, China
      • +4 more
      Jun 28, 2023

      Cervical Cancer, Condylomata Acuminata Trial in Nanjing (Recombinant Human Papillomavirus Nonavalent (Types

      Active, not recruiting
      • Cervical Cancer
      • Condylomata Acuminata
      • Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
      • Gardasil®9
      • Nanjing, Jiangsu, China
        Jiangsu Provincial Centre for Disease Control and Prevention
      Feb 10, 2022

      HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine Trial (SMS reminder for the HPV vaccination)

      Not yet recruiting
      • HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine
      • SMS reminder for the HPV vaccination
      • (no location specified)
      Sep 8, 2022

      Women's Values in Managing Human Papillomavirus (HPV)

      Not yet recruiting
      • Human Papilloma Virus Infection
      • No intervention
      • (no location specified)
      Nov 6, 2023

      Human Papilloma Virus, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Chicago (Carboplatin,

      Recruiting
      • Human Papilloma Virus
      • +4 more
      • Chicago, Illinois
        University Of Chicago Medicine Comprehensive Cancer Center
      Jun 3, 2022

      HPV Infection, HPV-Related Cervical Carcinoma Trial in Liuzhou (11-valent recombinant human papilloma virus vaccine (Hansenula

      Completed
      • HPV Infection
      • HPV-Related Cervical Carcinoma
      • 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)
      • Placebo
      • Liuzhou, Guangxi, China
        Liuzhou Center for Disease Control and Prevention
      Nov 23, 2021

      Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

      Recruiting
      • Cervical Cancer
      • +13 more
      • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
      • GARDASIL®
      • Rongan County, Guangxi Zhuang Autonomous Region, China
        Rongan County Center for Disease Control and Prevention
      Feb 20, 2022

      HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

      Completed
      • HPV Infections
      • +14 more
      • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
      • Active Comparator: GARDASIL ®9
      • Guangxi, China
        Guangxi Zhuang Autonomous Region Center for Disease Control and
      May 9, 2022